Discontinuation of azacitidine in acute myeloid leukemia: a feasible option? Boerekamps A, Hamberg P, Libourel EJ. Ann Hematol 2022 Aug 4. pii: 10.1007/s00277-022-04939.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boerekamps A, Hamberg P, Libourel EJ. Discontinuation of azacitidine in acute myeloid leukemia: a feasible option? Ann Hematol 2022 Aug 4. pii: 10.1007/s00277-022-04939.
PMID: 35927345